好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Fall Conference | C2 - Neuromuscular Junction Disorders: Myasthenia Gravis, Ocular, and MuSK Myasthenia

Friday 10/28/22
08:00 AM - 09:30 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Srikanth Muppidi, MD, FAAN
Neuromuscular and Clinical Neurophysiology (EMG)
Participants should become familiar with the developments in the diagnosis of autoimmune Myasthenia Gravis, currently available therapeutics, and potential new therapies in the pipeline with novel mechanisms of action.
1.50 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist
Didactic

Program Materials

Event Timeline
08:00 AM - 08:05 AM PDT Introduction Myasthenia Gravis
Srikanth Muppidi, MD, FAAN
08:05 AM - 08:45 AM PDT Speaker Myasthenia Gravis and Traditional Therapies
Shaida Khan, DO
08:45 AM - 09:25 AM PDT Speaker Myasthenia Gravis and Newer Therapies (Complement and FcRN)
Srikanth Muppidi, MD, FAAN
09:25 AM - 09:30 AM PDT Q&A Questions and Answers
Srikanth Muppidi, MD, FAAN, Shaida Khan, DO
Faculty Disclosures
Srikanth Muppidi, MD, FAAN Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. muppidi has received publishing royalties from a publication relating to health care.
Shaida Khan, DO Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma.